Proanthocyanidins potentiate hypothalamic leptin/STAT3 signalling and Pomc gene expression in rats with diet-induced obesity.
Dietary obesity is usually linked with hypothalamic leptin resistance, in which the primary impact is an interference in the homeostatic control of body weight and appetite. Notably, proanthocyanidins (PACs), which are the most abundant phenolic compounds present in human diet, modulate adiposity and food intake. The aim of this study was to assess whether PACs could re-establish appropriate leptin signalling in both the hypothalamus and peripheral tissues.



Male Wistar rats were fed either a standard chow diet (STD group, n=7) or a cafeteria diet (CD) for 13 weeks. The CD-fed rats were treated with either grape-seed PAC extract (GSPE) at 25 mg  per kg of body weight per day (CD+GSPE group, n=7) or with the vehicle (CD group, n=7) for the last 21 days of the study period. Specific markers for intracellular leptin signalling, inflammation and endoplasmic reticulum stress in the hypothalamus, liver, mesenteric white adipose tissue and skeletal muscle were analysed using immunoblotting and quantitative PCR.



GSPE treatment significantly reduced the food intake but did not reverse the hyperleptinemia and body wt gain assessed. However, the animals treated with GSPE exhibited greater hypothalamic activation of signal transducer and activator of transcription-3, which was associated with a rise in the Pomc mRNA levels compared with the CD group. In addition, this restoration of leptin responsiveness was accompanied by lower local inflammation and increased Sirt1 gene expression. The effects of the GSPE treatment in the peripheral tissues were not as evident as those in the hypothalamus, although the GSPE treatment significantly restored the mRNA levels of Socs3 and Ptp1b in the skeletal muscle.



The use of GSPE reduces hyperphagia and improves the central and peripheral leptin resistance associated with diet-induced obesity. Our results suggest that GSPE could exert these effects partially by increasing Sirt1 expression and preventing hypothalamic inflammation.
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
M
M
Ibars
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
A
A
Ardid-Ruiz
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
M
M
Suárez
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
B
B
Muguerza
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
C
C
Bladé
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
G
G
Aragonès
D000818:Animals; D001835:Body Weight; D059305:Diet, High-Fat; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D056604:Grape Seed Extract / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D020738:Leptin / Q000378:metabolism*; D050356:Lipid Metabolism / Q000187:drug effects; D008297:Male; D009765:Obesity / Q000378:metabolism*; D011333:Pro-Opiomelanocortin / Q000235:genetics*; D044945:Proanthocyanidins / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*
D056604:Grape Seed Extract; D020738:Leptin; D044945:Proanthocyanidins; D050796:STAT3 Transcription Factor; D011333:Pro-Opiomelanocortin
Int J Obes (Lond). 2009 Sep;33(9):1007-12
19581912
Mol Nutr Food Res. 2016 Aug;60(8):1789-803
26842874
J Pharmacol Exp Ther. 2003 Nov;307(2):544-9
12966151
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8878-83
9238071
Methods. 2001 Dec;25(4):402-8
11846609
FASEB J. 2008 Mar;22(3):659-61
17942826
Br J Nutr. 2012 Sep 28;108(6):1095-108
22186699
Biofactors. 2016 Jan-Feb;42(1):5-12
26762288
N Engl J Med. 1996 Feb 1;334(5):292-5
8532024
Arch Pharm Res. 2010 Nov;33(11):1741-6
21116776
Genes Nutr. 2009 Jun;4(2):151-6
19277751
Crit Rev Food Sci Nutr. 2006;46(7):543-50
16954063
Arch Pharm Res. 2013 Feb;36(2):201-7
23359004
J Nutr Biochem. 2015 Sep;26(9):912-20
26007288
J Clin Invest. 2012 Jan;122(1):153-62
22201683
Front Endocrinol (Lausanne). 2015 Jul 16;6:109
26236282
Nature. 2003 Feb 20;421(6925):856-9
12594516
Am J Physiol Regul Integr Comp Physiol. 2004 Jan;286(1):R143-50
12958061
J Med Food. 2010 Aug;13(4):926-33
20673061
Diabetologia. 2014 Apr;57(4):819-31
24374551
Arch Pharm Res. 2010 May;33(5):775-80
20512477
Brain Res. 2001 Feb 16;892(1):130-7
11172758
Peptides. 2002 Jun;23(6):1063-8
12126732
Nat Med. 1995 Dec;1(12):1311-4
7489415
Int J Obes (Lond). 2013 Apr;37(4):576-83
22584454
Metabolism. 2015 Jan;64(1):35-46
25497342
Food Funct. 2015 Apr;6(4):1053-71
25669490
Mol Nutr Food Res. 2013 Jan;57(1):34-47
23125162
J Nutr Biochem. 2011 Apr;22(4):380-7
20655715
Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E787-98
20103739
Nature. 2006 Sep 21;443(7109):289-95
16988703
Nature. 1998 Oct 22;395(6704):763-70
9796811
Appl Physiol Nutr Metab. 2009 Jun;34(3):396-402
19448705
J Nutr Biochem. 2014 Oct;25(10 ):1003-10
25011388
Food Funct. 2016 Jan;7(1):483-90
26514231
J Physiol Biochem. 2014 Jun;70(2):629-37
24610672
Cell. 2008 Oct 3;135(1):61-73
18854155
Obes Rev. 2015 Mar;16(3):207-24
25589226
J Nutr Biochem. 2015 Oct;26(10):987-95
26026838
Diabetes. 2015 Jun;64(6):2015-27
25626735
Cell Metab. 2012 Feb 8;15(2):150-6
22326217